We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$3.58B
AUM Growth
+$1.09B
Cap. Flow
+$140M
Cap. Flow %
3.91%
Top 10 Hldgs %
17.3%
Holding
3,189
New
308
Increased
616
Reduced
707
Closed
72

Sector Composition

Rank Sector Weight
1 Technology 6.55%
2 Financials 4.88%
3 Consumer Discretionary 4.45%
4 Healthcare 3.85%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGI
2901
Lazard Global Total Return & Income Fund
LGI
$240M
$2K ﹤0.01%
108
LKFN icon
2902
Lakeland Financial Corp
LKFN
$1.53B
$2K ﹤0.01%
+32
New +$2.1K
MBIO icon
2903
Mustang Bio
MBIO
$4.55M
$2K ﹤0.01%
1
MCFT icon
2904
MasterCraft Boat Holdings
MCFT
$590M
$2K ﹤0.01%
94
MEDP icon
2905
Medpace
MEDP
$16.5B
$2K ﹤0.01%
+13
New +$1.99K
MMSI icon
2906
Merit Medical Systems
MMSI
$5.32B
$2K ﹤0.01%
+37
New +$2.12K
MTRN icon
2907
Materion
MTRN
$6.04B
$2K ﹤0.01%
+30
New +$2.08K
NEO icon
2908
NeoGenomics
NEO
$2.13B
$2K ﹤0.01%
+50
New +$2.6K
NGNE icon
2909
Neurogene
NGNE
$712M
$2K ﹤0.01%
11
NMIH icon
2910
NMI Holdings
NMIH
$3.36B
$2K ﹤0.01%
+83
New +$1.93K
NSIT icon
2911
Insight Enterprises
NSIT
$4.38B
$2K ﹤0.01%
+21
New +$1.8K
NUAG icon
2912
Nuveen Enhanced Yield US Aggregate Bond ETF
NUAG
$95.1M
$2K ﹤0.01%
110
OPP
2913
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$191M
$2K ﹤0.01%
162
PAVE icon
2914
Global X US Infrastructure Development ETF
PAVE
$15.2B
$2K ﹤0.01%
85
-19,590
-100% -$451K
PBFS icon
2915
Pioneer Bancorp
PBFS
$434M
$2K ﹤0.01%
200
PBH icon
2916
Prestige Consumer Healthcare
PBH
$2.6B
$2K ﹤0.01%
63
PRG icon
2917
PROG Holdings
PRG
$1.71B
$2K ﹤0.01%
+50
New +$2.5K
PRGO icon
2918
Perrigo
PRGO
$1.78B
$2K ﹤0.01%
68
PSQ icon
2919
ProShares Short QQQ
PSQ
$722M
$2K ﹤0.01%
39
RBC icon
2920
RBC Bearings
RBC
$18B
$2K ﹤0.01%
+15
New +$2.82K
RDY icon
2921
Dr. Reddy's Laboratories
RDY
$10.2B
$2K ﹤0.01%
+145
New +$1.86K
RMAX icon
2922
RE/MAX Holdings
RMAX
$242M
$2K ﹤0.01%
+55
New +$2.16K
RMT
2923
Royce Micro-Cap Trust
RMT
$761M
$2K ﹤0.01%
218
-293
-57% -$3.34K
SABR icon
2924
Sabre
SABR
$835M
$2K ﹤0.01%
150
+50
+50% +$678
SBI
2925
Western Asset Intermediate Muni Fund
SBI
$108M
$2K ﹤0.01%
270

Similar funds

Geneos Wealth Management's Q1 2021 Portfolio in Review

As of Q1 2021, Geneos Wealth Management held 3,189 positions worth $3.58B, up 44% from $2.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Geneos Wealth Management deployed $140M of net new capital in Q1 2021, opening 308 new positions and adding to 616 existing holdings. Its largest new stake was Vanguard S&P Small-Cap 600 Value ETF: 372,978 shares worth $33M.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 7.5% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was ProShares Ultra Financials, an estimated $18.1M trimmed.

  • Geneos Wealth Management's largest Q1 2021 buy was Vanguard S&P Small-Cap 600 Value ETF: 372,978 shares worth $33M.
  • Geneos Wealth Management added most to Vanguard Morningstar Large-Cap ETF in Q1 2021, an estimated $27M increase.
  • Geneos Wealth Management's biggest Q1 2021 reduction was ProShares Ultra Financials, cutting an estimated $18.1M.
  • Geneos Wealth Management fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q1 2021, selling an estimated $156K.
  • Geneos Wealth Management's ten largest holdings make up 17% of its $3.58B portfolio in Q1 2021.
  • Geneos Wealth Management opened 308 new positions and closed 72 in Q1 2021.
  • Geneos Wealth Management's portfolio value rose 44% quarter-over-quarter to $3.58B.

Based on Geneos Wealth Management's 13F filing for Q1 2021, filed 17 Jun 2021.